LARPRUVO Trademark

Trademark Overview


On Thursday, December 17, 2015, a trademark application was filed for LARPRUVO with the United States Patent and Trademark Office. The USPTO has given the LARPRUVO trademark a serial number of 86852651. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 21, 2019. This trademark is owned by Eli Lilly and Company. The LARPRUVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
larpruvo

General Information


Serial Number86852651
Word MarkLARPRUVO
Filing DateThursday, December 17, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 28, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, January 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2018EXTENSION 4 GRANTED
Thursday, June 7, 2018EXTENSION 4 FILED
Thursday, June 7, 2018TEAS EXTENSION RECEIVED
Thursday, November 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 21, 2017EXTENSION 3 GRANTED
Tuesday, November 21, 2017EXTENSION 3 FILED
Tuesday, November 21, 2017TEAS EXTENSION RECEIVED
Friday, June 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017EXTENSION 2 GRANTED
Friday, June 2, 2017EXTENSION 2 FILED
Friday, June 2, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2016EXTENSION 1 GRANTED
Tuesday, November 29, 2016EXTENSION 1 FILED
Monday, December 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 29, 2016TEAS EXTENSION RECEIVED
Tuesday, June 21, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 24, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 24, 2016ASSIGNED TO LIE
Wednesday, March 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2016ASSIGNED TO EXAMINER
Monday, December 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 21, 2015NEW APPLICATION ENTERED IN TRAM